NCT06255691

Brief Summary

There is a lack of data on patients self-reported outcomes (PROMs) on health-related quality of life (HRQoL)and symptoms on anxiety and depression 10 years after Surgical After Aortic Valve Replacement (SAVR), and patient reported experiences with the health services (PREMS). In this 10-years follow-up study on patients alive from the study named "The Impact of 24/ 7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial (AVRre)" NCT02522663 we will repeat the survey on symtoms on anxiety and depresion using Hospital Anxiety and depression Scale (HADS), health-related quality of life (EQ-5D) and questions about experiences with the health services.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
282

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Apr 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Apr 2025Dec 2027

First Submitted

Initial submission to the registry

February 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 13, 2024

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 10, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

February 13, 2024

Status Verified

February 1, 2024

Enrollment Period

2.1 years

First QC Date

February 4, 2024

Last Update Submit

February 4, 2024

Conditions

Keywords

aortic valve replacementlongitudinal studypatient reported outcomesymptoms of anxietyhealth-related quality of life

Outcome Measures

Primary Outcomes (2)

  • Symptoms of anxiety and depression

    Symptoms of anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS)

    10 year follow-up

  • Health related quality of life

    EQ-5D-3L questionnaire from The EuroQol Group to measure health related quality of life.

    10 year follow-up

Secondary Outcomes (1)

  • Experiences with health services

    10 year follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

10 year follow-up of the participants in the AVrRe study

You may qualify if:

  • Treatment with AVR (biological or mechanical) single, AVR (b or m)+aortocoronary bypass, AVR (b or m)+supra coronary tube graft Can understand, speak and write native Language (norwegian), and be able to fill in the questionnaires

You may not qualify if:

  • Patients not alive after the AVRre study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Valve StenosisAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Stein Ove O Danielsen, PhD

    OsloMet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stein O Danielsen, PhD

CONTACT

Irene Lie, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

February 4, 2024

First Posted

February 13, 2024

Study Start

April 10, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

February 13, 2024

Record last verified: 2024-02